1. Construction of a recombinant vaccinia virus expressing Babesia gibsoni thrombospondin-related anonymous protein and evaluation of its immunogenicity in mice
- Author
-
Y Nishikawa, Youn-Kyoung Goo, Jinlin Zhou, G H Zhang, A. Kumagai, Mingming Liu, Houshuang Zhang, Honglin Jia, Chinatsu Nakamura, and Xuenan Xuan
- Subjects
Protozoan Vaccines ,medicine.medical_specialty ,030231 tropical medicine ,Protozoan Proteins ,Antibodies, Protozoan ,Babesia ,Vaccinia virus ,Biology ,medicine.disease_cause ,law.invention ,03 medical and health sciences ,BgTRAP ,Mice ,0302 clinical medicine ,law ,Molecular genetics ,Babesia gibsoni ,vaccine ,Gene expression ,medicine ,Animals ,Escherichia coli ,Gene ,Antiserum ,Mice, Inbred BALB C ,Molecular mass ,Immunogenicity ,Immune Sera ,Virology ,Recombinant Proteins ,Recombinant DNA ,Female - Abstract
application/pdf, Previously, we have identified a gene encoding thrombospondin-related anonymous protein of Babesia gibsoni (BgTRAP), and have shown that the antisera raised against recombinant BgTRAP expressed in Escherichia coli inhibited the growth of parasites. In the present study, a recombinant vaccinia virus expressing the BgTRAP (VV/BgTRAP) was constructed. A specific band corresponding to a molecular mass of 80 kDa, which was similar to that of native BgTRAP on the merozoites of B. gibsoni, was detected in the supernatant of VV/BgTRAP-infected RK13 cells. Moreover, mice inoculated with VV/BgTRAP produced antibody that specifically reacted with the native BgTRAP on parasites. These results indicated that the recombinant vaccinia virus expressing BgTRAP might be a vaccine candidate against canine B. gibsoni infection.
- Published
- 2021